Anti-DLL3 drug conjugates for treating tumors at risk of neuroendocrine transition

Methods of treating tumors at risk for neuroendocrine transition using anti-delta-like ligand 3 (DLL3) antibody drug conjugates (ADCs) are provided.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAUNDERS, LAURA, HYDUKE, DANIEL R, STULL, ROBERT A, YOU, ENYING
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods of treating tumors at risk for neuroendocrine transition using anti-delta-like ligand 3 (DLL3) antibody drug conjugates (ADCs) are provided.